4.7 Article

Chemopreventive Effects of Dietary Isothiocyanates in Animal Models of Gastric Cancer and Synergistic Anticancer Effects With Cisplatin in Human Gastric Cancer Cells

期刊

FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.613458

关键词

dietary (or plant) isothiocyanates; gastric cancer; glutathione; glutamine; cisplatin; mice

资金

  1. Liaison Committee [46056636/46056928/90061700/90061701]
  2. Joint Program of the Medical Faculty of NTNU
  3. Research Council of Norway
  4. Cancer Foundation of St. Olavs Hospital (Kreftfondet ved St. Olavs hospital)
  5. Japan Society for the Promotion of Science (JSPS) [15F14741]
  6. Scandinavia-Japan Sasakawa Foundation (SJSF)
  7. Grants-in-Aid for Scientific Research [15F14741] Funding Source: KAKEN

向作者/读者索取更多资源

Natural isothiocyanates from edible vegetables have shown potential as chemopreventive agents against various types of cancer. This study focused on studying the potential of isothiocyanates in chemoprevention and enhancing the efficacy of cytotoxic drugs in gastric cancer treatment. The results demonstrated that PEITC exhibited anti-cancer effects, particularly when administered before tumor initiation, suggesting a chemopreventive role in gastric cancer, and that pretreatment with PEITC enhanced the anti-cancer effects of cisplatin possibly by reducing glutathione levels, indicating a potential combination strategy for chemotherapy.
Naturally occurring isothiocyanates (ITCs) from edible vegetables have shown potential as chemopreventive agents against several types of cancer. The aims of the present study were to study the potential of ITCs in chemoprevention and in potentiating the efficacy of cytotoxic drugs in gastric cancer treatment. The chemoprevention was studied in chemically induced mouse model of gastric cancer, namely N-methyl-N-nitrosourea (MNU) in drinking water, and in a genetically engineered mouse model of gastric cancer (the so-called INS-GAS mice). The pharmacological effects of ITCs with or without cisplatin were studied in human gastric cell lines MKN45, AGS, MKN74 and KATO-III, which were derived from either intestinal or diffused types of gastric carcinoma. The results showed that dietary phenethyl isothiocyanate (PEITC) reduced the tumor size when PEITC was given simultaneously with MNU, but neither when administrated after MNU nor in INS-GAS mice. Treatments of gastric cancer cells with ITCs resulted in a time- and concentration-dependent inhibition on cell proliferation. Pretreatment of gastric cancer cells with ITCs enhanced the inhibitory effects of cisplatin (but not 5-fluorouracil) in time- and concentration-dependent manners. Treatments of gastric cancer cells with PEITC plus cisplatin simultaneously at different concentrations of either PEITC or cisplatin exhibited neither additive nor synergetic inhibitory effect. Furthermore, PEITC depleted glutathione and induced G(2)/M cell cycle arrest in gastric cancer cells. In conclusion, the results of the present study showed that PEITC displayed anti-cancer effects, particularly when given before the tumor initiation, suggesting a chemopreventive effect in gastric cancer, and that pretreatment of PEITC potentiated the anti-cancer effects of cisplatin, possibly by reducing the intracellular pool of glutathione, suggesting a possible combination strategy of chemotherapy with pretreatment with PEITC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据